Close Menu

ISO certification

The certification enables the reagent maker to create optimizing products for use beyond the research market.

CBC also recently achieved ISO DIN/EN 17025:2005 accreditation for the extraction of total RNA from body fluids and the analysis of microRNA and mRNA.

The Center for Human Genetics and Laboratory Medicine's Prenatalis test is based on Illumina's Verifi technology. 

The recertification covers design, production, and sale of the firm's qNPA technology-based gene expression analysis products and services.

The company achieved ISO 13485 certification for two facilities, extending their capabilities to manufacture and offer raw materials used in diagnostic assays.

The certification covers the development, production, and distribution of in vitro diagnostics for autoimmune disease.

The test uses mitochondrial DNA hybridization arrays to detect up to 21 animals that are ingredients or contaminants in food for humans, pets, and livestock.

The New Zealand-based cancer diagnostics firm received ISO 15189:2012 accreditation.

The certification follows CLIA certification and CAP accreditation for the firm's Cambridge, Mass. next-generation sequencing laboratory.

The accreditation is for Illumina-based sequencing services and covers HiSeq and MiSeq sequencing, RNA and DNA library preparation, and other services. 

Pages

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.